Comparison

Semaglutide vs Tirzepatide: Comparing GLP-1 Weight Loss Medications

Both are FDA-approved GLP-1 medications for weight loss and diabetes. Tirzepatide is a newer dual-agonist (GIP/GLP-1) showing greater weight loss in trials, while Semaglutide has more long-term safety data.

Semaglutide
Typical Dose: 0.25-2.4 mg
Frequency: Once weekly
Route: Subcutaneous injection
FDA Approved: Yes
View Semaglutide Details
Tirzepatide
Typical Dose: 2.5-15 mg
Frequency: Once weekly
Route: Subcutaneous injection
FDA Approved: Yes
View Tirzepatide Details
Key Differences
AspectSemaglutideTirzepatide
MechanismGLP-1 receptor agonist onlyDual GIP + GLP-1 receptor agonist
Weight Loss15-17% in trialsUp to 22.5% in trials
Dosing0.25-2.4 mg weekly2.5-15 mg weekly
FDA StatusApproved since 2017 (diabetes), 2021 (weight)Approved since 2022 (diabetes), 2023 (weight)
FormsInjectable and oral (Rybelsus)Injectable only
When to Use Each

Semaglutide May Be Better For:

  • When long-term safety data is priority
  • Cardiovascular risk reduction focus
  • Insurance coverage considerations
  • Oral option preferred (Rybelsus)

Tirzepatide May Be Better For:

  • Maximum weight loss is goal
  • Superior A1C reduction needed
  • GLP-1 alone insufficient
  • Better GI tolerance (some patients)

Both Are Good For:

Type 2 diabetes managementChronic weight managementMetabolic syndromeCardiovascular risk reduction
Side Effects Comparison

Semaglutide

  • Nausea
  • Vomiting
  • Diarrhea
  • Constipation
  • Injection site reactions

Tirzepatide

  • Nausea
  • Diarrhea
  • Decreased appetite
  • Vomiting
  • Constipation
The Verdict

Tirzepatide shows superior weight loss results in head-to-head trials. However, Semaglutide has more long-term safety data and an oral option. Both are effective; choice often depends on insurance, availability, and individual response.

Research Data

Semaglutide

100
Animal Studies
50
Human Studies

Tirzepatide

50
Animal Studies
30
Human Studies

Compare Different Peptides?

Use our interactive tool to compare any peptides side-by-side.

Open Compare Tool

Research Purposes Only

This comparison is for educational purposes. Consult a healthcare provider before using any peptides.